Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

Bedognetti D, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P.

J Natl Cancer Inst. 2011 Oct 19;103(20):1529-39. doi: 10.1093/jnci/djr351. Epub 2011 Sep 15.

2.

Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.

Jankowitz RC, McGuire KP, Davidson NE.

Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032. Review.

PMID:
24074781
3.

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thürlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A.

Lancet. 2000 May 27;355(9218):1869-74. Review.

PMID:
10866443
4.

Extended adjuvant chemotherapy in endocrine non-responsive disease.

Colleoni M, Munzone E.

Breast. 2013 Aug;22 Suppl 2:S161-4. doi: 10.1016/j.breast.2013.07.031. Review.

PMID:
24074780
5.

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.

Fujii T, Le Du F, Xiao L, Kogawa T, Barcenas CH, Alvarez RH, Valero V, Shen Y, Ueno NT.

JAMA Oncol. 2015 Dec;1(9):1311-8. doi: 10.1001/jamaoncol.2015.3062. Review.

6.

Italian Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA Trials.

Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Pacini P, Gallo L, Sismondi P, Giai M, Genta F, Mustacchi G, Agostara B, Bolognesi A, Villa E, Schieppati G, Ausili Cefaro GP, Bellantone R, Farris A, Sassi M, Patrone F.

Recent Results Cancer Res. 1998;152:453-70. Review.

PMID:
9928580
7.

Management of breast cancer in very young women.

Freedman RA, Partridge AH.

Breast. 2013 Aug;22 Suppl 2:S176-9. doi: 10.1016/j.breast.2013.07.034. Review.

PMID:
24074783
8.

[Impact of taxanes in the adjuvant setting of node-negative breast cancers].

Lagha A, Chraiet N, Labidi S, Krimi S, Ayadi M, Gligorov J, Boussen H.

Bull Cancer. 2013 May;100(5):465-71. doi: 10.1684/bdc.2013.1743. Review. French.

PMID:
23613145
9.
10.

[Adjuvant chemotherapy for breast cancer--a current controversy].

Jinno H, Ikeda T, Kubouchi K, Fujiwara K, Kitajima M.

Gan To Kagaku Ryoho. 2004 Feb;31(2):176-80. Review. Japanese.

PMID:
14997747
11.

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM.

J Natl Cancer Inst. 2010 Dec 15;102(24):1845-54. doi: 10.1093/jnci/djq409. Epub 2010 Nov 23. Review.

12.

Endocrine therapy of breast cancer.

Goldhirsch A, Colleoni M, Gelber RD.

Ann Oncol. 2002;13 Suppl 4:61-8. Review. No abstract available.

PMID:
12401668
13.

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.

Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM.

BMC Cancer. 2013 May 16;13:240. doi: 10.1186/1471-2407-13-240. Review.

14.

Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.

Tack DK, Palmieri FM, Perez EA.

Oncology (Williston Park). 2004 Oct;18(11):1367-76; discussion 1378, 1381. Review.

15.

Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.

Bedard PL, Di Leo A, Piccart-Gebhart MJ.

Nat Rev Clin Oncol. 2010 Jan;7(1):22-36. doi: 10.1038/nrclinonc.2009.186. Epub 2009 Dec 8. Review.

PMID:
19997076
16.

Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials.

Petrelli F, Cabiddu M, Coinu A, Borgonovo K, Ghilardi M, Lonati V, Barni S.

Breast Cancer Res Treat. 2015 Jun;151(2):251-9. doi: 10.1007/s10549-015-3405-4. Epub 2015 Apr 28. Review.

PMID:
25917869
17.

Randomized trials of high dose chemotherapy for breast cancer.

Antman KH.

Biochim Biophys Acta. 2001 Mar 21;1471(3):M89-98. Review.

PMID:
11250065
18.

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.

Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, Seruga B, Tannock IF, Ocana A, Amir E.

J Natl Cancer Inst. 2014 Jan;106(1):djt319. doi: 10.1093/jnci/djt319. Epub 2013 Nov 22. Review.

PMID:
24273215
19.

The continued evidence from overviews: what is the clinical utility?

Turner N, Biganzoli L, Malorni L, Migliaccio I, Moretti E, Pestrin M, Sanna G, Siclari O, Di Leo A.

Breast. 2013 Aug;22 Suppl 2:S8-11. doi: 10.1016/j.breast.2013.07.002. Review.

PMID:
24074798
20.

Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.

Iacovelli R, Pietrantonio F, Maggi C, de Braud F, Di Bartolomeo M.

Crit Rev Oncol Hematol. 2016 Feb;98:24-8. doi: 10.1016/j.critrevonc.2015.09.002. Epub 2015 Oct 9. Review.

PMID:
26481953

Supplemental Content

Support Center